CD8A and neoplasm: In addition, a strong expansion of OVA257–264-specific CD8+ T cells was observed in the peripheral blood of tumor-bearing mice 7 days after immunization with rMVA vectors in both tumor models (Supplementary Fig. 2,C, D; see Supplementary Fig. 1 for flow cytometry gating strategies).